T

TRYP Therapeutics Inc
CNSX:TRYP

Watchlist Manager
TRYP Therapeutics Inc
CNSX:TRYP
Watchlist
Price: 0.06 CAD Market Closed
Market Cap: 5.8m CAD

Relative Value

There is not enough data to reliably calculate the relative value of TRYP.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TRYP Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.7
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-1.2
Industry
21.5
Forward
-2
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.6
Industry
16.7
vs History
vs Industry
Median 3Y
4.9
Median 5Y
-1.7
Industry
23
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-1.2
Industry
2.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.6
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-1
Industry
13.2
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-1
Industry
16.6
Forward
-0.7
vs History
vs Industry
Median 3Y
-1
Median 5Y
-1.4
Industry
15.8
vs History
vs Industry
Median 3Y
-1
Median 5Y
-1.4
Industry
19
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-2.3
Industry
2

Multiples Across Competitors

TRYP Competitors Multiples
TRYP Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
TRYP Therapeutics Inc
CNSX:TRYP
5.8m CAD 0 -1.2 -0.9 -0.9
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55.2 37 39.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
262.5B CHF 4.3 27.8 11.9 13.9
UK
AstraZeneca PLC
LSE:AZN
212B GBP 4.9 30.5 108.7 159.1
CH
Novartis AG
SIX:NOVN
211.3B CHF 4.8 18.6 11.8 15.2
US
Merck & Co Inc
NYSE:MRK
264.6B USD 4.1 13.9 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.7 14.2 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
212.8B USD 91.8 -72.8 337 845
US
Pfizer Inc
NYSE:PFE
142B USD 2.3 14.4 7.4 10.1
P/E Multiple
Earnings Growth PEG
CA
T
TRYP Therapeutics Inc
CNSX:TRYP
Average P/E: 24.3
Negative Multiple: -1.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.2
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.5
38%
0.8
CH
Novartis AG
SIX:NOVN
18.6
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.2
4%
3.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -72.8 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.4
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
T
TRYP Therapeutics Inc
CNSX:TRYP
Average EV/EBITDA: 439.6
Negative Multiple: -0.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.9
4%
3
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
CH
Novartis AG
SIX:NOVN
11.8
6%
2
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
2%
5
IE
E
Endo International PLC
LSE:0Y5F
337
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
T
TRYP Therapeutics Inc
CNSX:TRYP
Average EV/EBIT: 1 883
Negative Multiple: -0.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.7
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.9
5%
2.8
UK
AstraZeneca PLC
LSE:AZN
159.1
23%
6.9
CH
Novartis AG
SIX:NOVN
15.2
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
1%
11.5
IE
E
Endo International PLC
LSE:0Y5F
845
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3